AAAAAA

   
Results: 1-13 |
Results: 13
CYCLOSPORINE MICROEMULSION INCREASES DRUG EXPOSURE AND REDUCES ACUTE REJECTION WITHOUT INCREMENTAL TOXICITY IN DE-NOVO RENAL-TRANSPLANTATION
Authors: KEOWN P NIESE D
Citation: P. Keown et D. Niese, CYCLOSPORINE MICROEMULSION INCREASES DRUG EXPOSURE AND REDUCES ACUTE REJECTION WITHOUT INCREMENTAL TOXICITY IN DE-NOVO RENAL-TRANSPLANTATION, Kidney international, 54(3), 1998, pp. 938-944
CYCLOSPORINE MICROEMULSION FORMULATION (NEORAL) IN TRANSPLANTATION - PHARMACOKINETIC PHARMACODYNAMIC RELATIONSHIPS/
Authors: MUELLER EA NIESE D MELLEIN B
Citation: Ea. Mueller et al., CYCLOSPORINE MICROEMULSION FORMULATION (NEORAL) IN TRANSPLANTATION - PHARMACOKINETIC PHARMACODYNAMIC RELATIONSHIPS/, Transplantation proceedings, 30(5), 1998, pp. 1694-1696
RANDOMIZED, DOUBLE-BLIND, ONE-YEAR STUDY OF THE SAFETY AND TOLERABILITY OF CYCLOSPORINE MICROEMULSION COMPARED WITH CONVENTIONAL CYCLOSPORINE IN RENAL-TRANSPLANT PATIENTS
Authors: FREI UA NEUMAYER HH BUCHHOLZ B NIESE D MUELLER EA
Citation: Ua. Frei et al., RANDOMIZED, DOUBLE-BLIND, ONE-YEAR STUDY OF THE SAFETY AND TOLERABILITY OF CYCLOSPORINE MICROEMULSION COMPARED WITH CONVENTIONAL CYCLOSPORINE IN RENAL-TRANSPLANT PATIENTS, Transplantation, 65(11), 1998, pp. 1455-1460
CLINICAL DEVELOPMENT OF A CYCLOSPORINE MICROEMULSION IN TRANSPLANTATION
Authors: KOVARIK JM MUELLER EA NIESE D
Citation: Jm. Kovarik et al., CLINICAL DEVELOPMENT OF A CYCLOSPORINE MICROEMULSION IN TRANSPLANTATION, Therapeutic drug monitoring, 18(4), 1996, pp. 429-434
CLINICAL AND IMMUNOLOGICAL CHARACTERISTICS OF TRANSPLANT RECIPIENTS WITH RECURRENT ACUTE REJECTION EPISODES
Authors: JACOBS U NIESE D BRENSING KA KLEIN B BUSZELLO H KLEHR HU
Citation: U. Jacobs et al., CLINICAL AND IMMUNOLOGICAL CHARACTERISTICS OF TRANSPLANT RECIPIENTS WITH RECURRENT ACUTE REJECTION EPISODES, Transplantation proceedings, 28(6), 1996, pp. 3231-3233
IMMUNOLOGICAL DISORDERS IN POSTTRANSPLANT LYMPHOMA - THERAPEUTIC IMPLICATIONS
Authors: JACOBS U NIESE D BRENSING KA EISHUBINGER A BUSZELLO H KLEHR HU
Citation: U. Jacobs et al., IMMUNOLOGICAL DISORDERS IN POSTTRANSPLANT LYMPHOMA - THERAPEUTIC IMPLICATIONS, Transplantation proceedings, 28(6), 1996, pp. 3249-3250
COLD ISCHEMIA, HISTOCOMPATIBILITY, DONOR AND RECIPIENT AGE - IMPACT ON EARLY LYMPHOCYTE SUBSETS AND TRANSPLANT OUTCOME
Authors: JACOBS U NIESE D KLEIN B PAAR D MIERSCH W KLEHR HU
Citation: U. Jacobs et al., COLD ISCHEMIA, HISTOCOMPATIBILITY, DONOR AND RECIPIENT AGE - IMPACT ON EARLY LYMPHOCYTE SUBSETS AND TRANSPLANT OUTCOME, Transplantation proceedings, 28(6), 1996, pp. 3251-3252
SAFETY AND TOLERABILITY OF NEORAL IN TRANSPLANT RECIPIENTS
Authors: FEUTREN G WONG R JIN J NIESE D MELLEIN B
Citation: G. Feutren et al., SAFETY AND TOLERABILITY OF NEORAL IN TRANSPLANT RECIPIENTS, Transplantation proceedings, 28(4), 1996, pp. 2177-2182
EVIDENCE FOR EARLIER STABILIZATION OF CYCLOSPORINE PHARMACOKINETICS IN DE-NOVO RENAL-TRANSPLANT PATIENTS RECEIVING A MICROEMULSION FORMULATION
Authors: KOVARIK JM MUELLER EA RICHARD F NIESE D HALLORAN PF JEFFERY J PAUL LC KEOWN PA
Citation: Jm. Kovarik et al., EVIDENCE FOR EARLIER STABILIZATION OF CYCLOSPORINE PHARMACOKINETICS IN DE-NOVO RENAL-TRANSPLANT PATIENTS RECEIVING A MICROEMULSION FORMULATION, Transplantation, 62(6), 1996, pp. 759-763
A DOUBLE-BLIND RANDOMIZED STUDY OF SANDIMMUNE-NEORAL VERSUS SANDIMMUNE IN NEW RENAL-TRANSPLANT RECIPIENTS - RESULTS AFTER 12 MONTHS
Authors: NIESE D
Citation: D. Niese, A DOUBLE-BLIND RANDOMIZED STUDY OF SANDIMMUNE-NEORAL VERSUS SANDIMMUNE IN NEW RENAL-TRANSPLANT RECIPIENTS - RESULTS AFTER 12 MONTHS, Transplantation proceedings, 27(2), 1995, pp. 1849-1856
QEEG IN HEMOPHILIACS WITH HIV-INFECTION
Authors: RIEDEL RR ALPER K BULAU P BRACKMANN HH NIESE D SCHIECK U GUNTHER W
Citation: Rr. Riedel et al., QEEG IN HEMOPHILIACS WITH HIV-INFECTION, Clinical EEG electroencephalography, 26(2), 1995, pp. 84-91
SANDIMMUN NEORAL, A NEW ORAL FORMULATION OF CYCLOSPORINE-A WITH IMPROVED PHARMACOKINETIC CHARACTERISTICS - SAFETY AND TOLERABILITY IN RENAL-TRANSPLANT PATIENTS
Authors: TAESCH S NIESE D MUELLER EA
Citation: S. Taesch et al., SANDIMMUN NEORAL, A NEW ORAL FORMULATION OF CYCLOSPORINE-A WITH IMPROVED PHARMACOKINETIC CHARACTERISTICS - SAFETY AND TOLERABILITY IN RENAL-TRANSPLANT PATIENTS, Transplantation proceedings, 26(6), 1994, pp. 3147-3149
USE OF SANDIMMUN-NEORAL IN RENAL-TRANSPLANT PATIENTS
Authors: FREI U TAESCH S NIESE D
Citation: U. Frei et al., USE OF SANDIMMUN-NEORAL IN RENAL-TRANSPLANT PATIENTS, Transplantation proceedings, 26(5), 1994, pp. 2928-2931
Risultati: 1-13 |